Now that the 12th World Conference on Lung Cancer in Seoul is well over and we have had time to digest the presented data, we are looking forward to many other IASLC activities in the near future. We are happy to announce many new fellowships for 2008 and all the members should encourage young investigators to apply for these fellowships. That is the future for lung cancer research and for IASLC! In this Newsletter we are also presenting the new IASLC Tobacco Declaration and it is an obligation for all of us to secure distribution and proper implementation. It is also very encouraging seeing the increase in our membership every month. We hope that each member will encourage colleagues to join our organization. It is the intention of the IASLC Newsletter to facilitate communications among our members. We would like to communicate events and news of relevance from the different countries. However, for this to happen we need input from the IASLC members. The Editor would appreciate input from the IASLC members about events of interest in their country or region. December 1st, 2007 is the dead-line for the application for the 15th World Conference on Lung Cancer (“Rest of the World), and at the next Board of Directors meeting in February 2008 candidates for site-visits will be selected.
Fred R. Hirsch, MD, PhD
15th World Conference on Lung Cancer
The IASLC World Conference is soliciting bids for the 15th World Conference on Lung Cancer to take place in Asia, The Pacific Rim or regions outside North American and Europe.
The IASLC World Conference on Lung Cancer is held every second year and will take place in Asia, The Pacific Rim or regions outside North American and Europe in 2013. The attendance can be expected to range from 5,000 – 8,000 (including accompanying persons)
The proposal should include the following:
- Location - The 15th World Conference will take place in a Non-North America/Non-Europe country.
- Time period -The duration of the Conference is 4-5 days.
- Facilities (for conferences, workshops, hotels, etc.) The meeting must take place in a location with adequate facilities to comfortably accommodate the expected attendance (up to 8000) Flight connections must be accessible from anywhere in the world.
- Organizers - The group should include persons with a demonstrated track record within the IASLC who can put together a small local Organizing Program Committee to coordinate the planning of the meeting, and they should preferably have previous experience with similar arrangements.
- Local/national support - If possible, support should be requested from national societies or local organizers.
- Budget proposal - A detailed budget must outline all expected revenues and expenses.
- Suggestions for social events
A copy of the detailed ‘Guidelines for the International Association for the Study of Lung Cancer World Conferences’ can be obtained from the IASLC website www.iaslc.org. Applications will be accepted after September 2007, and not later than December 1, 2007. The applications will be reviewed by the IASLC Board of Directors at the Board meeting in February 2008. Finalists will be notified in March 2008 and selected IASLC Officers, staff, Board members will conduct site visits to the finalist sites in the spring of 2008. A final decision will be made no later than the Board meeting in June 2008. Further information can be obtained from members of the Board and from the IASLC Office.
Please apply by e-mail firstname.lastname@example.org latest December 1st, 2007.
International Association for the Study of Lung Cancer
Executive Director Paul A. Bunn, Jr., MD
University of Colorado Cancer Center
P.O.Box 6508, MS F 434, Aurora, Colorado 80045-0511, USA
A new activity in 2008 is the IASLC/ESMO joint Lung Cancer Conference in Geneva, April 23-26, 2008. We hope that as many of you as possible will attend this conference and submit abstracts. Deadline for abstract submission is January 9, 2008. For more information please go to our website www.iaslc.org.
IASLC/PCF Prevent Cancer Foundation Fellowship Award
2 years duration
IASLC Lung Cancer Fellowship Award/Young Investigators Award
2 years duration
The IASLC is proud to announce a continuation and expansion of the IASLC Fellowship and Young Investigators Programs. Overall there are 17 potential awards for two years each. There are 4 awards in prevention and translational lung cancer research that are jointly sponsored with the Prevent Cancer Foundation (PCF) through educational grants from Eli Lilly (3) and Bristol-Myers Squibb (1). There are 13 unrestricted awards in any field of lung cancer research supported by educational grants from GlaxoSmithKline (3), Sanofi-Aventis (3), AstraZeneca (3), Celgene (1), Pfizer (1), Eli Lilly (1), and OSI (1). This year 8 new unrestricted awards of $40,000 each year for 2 years are available for competition. We are now requesting application for these Fellowships and Young Investigator awards to be awarded in 2008. The goal is to reward scientific excellence and to encourage innovative investigations in the field of lung cancer prevention research and translational research with a potential impact on the management of lung cancer. The applications will be evaluated by a Scientific Review Panel; the deadline for submission of the application is January 15, 2008. A decision on applications will be reached by March 2008. Application forms can be found at the website: www.iaslc.org
Please e-mail you application to: pia.Hirsch@uchsc.edu latest January 15, 2008
IASLC 2007 Tobacco Declaration
Lung cancer is the leading cause of cancer death in the world. The incidence is rising at an alarming rate in both men and women, particularly in the developing world. Ninety percent of cases are caused by active or passive smoking, and therefore, could be avoided or prevented. Smoking is a major factor in the development of cancers, cardiovascular disease and chronic lung disease. If the global epidemic caused from tobacco, particularly the epidemic of lung cancer deaths, is to be decreased in the next few decades, smoking cessation must be a key component of our strategy. Because smoking tobacco most often begins in childhood or early adolescence, nicotine addiction in this population must be prevented.
In order to help achieve its goal of eliminating lung cancer, the IASLC.
Requests governments to:
1. Ratify the Framework Convention on Tobacco Control and work to speedily implement its Articles.
2. Work within each of the members Cancer Centers or Clinics to promote smoking cessation and a complete smoke free workplace campus.
3. Promote smoking and all tobacco prevention programs, particularly those that are focused on youths.
4. Promote legislation or regulations that enforce smoke free public places, including transportation systems particularly to protect non-smokers from the effects of secondhand smoking.
5. Promote educational programs that warn of the deadly effects of tobacco on health, including programs with the school systems.
6. Increase taxes on tobacco in order to decrease its use.
7. Encourage governments to enforce anti-smuggling laws with increased surveillance
8. Initiate legislative action for ultimate elimination of manufacture and sales of tobacco products
9. Encourage other medical societies and health care institutions to join in campaigns against smoking and for anti-smoking education.
10. Encourage all health care providers to receive training in counseling on stopping smoking.
11. Requests all industrial sectors and media organs to eliminate tobacco advertising and marketing.
12. Promises to produce materials that will aid in education concerning smoking and lung cancer.
New members October – November 2007
El Habib Dakir Taia
Sergio Tadeu Pereira
Joan H. Schiller
Luis Alberto Mas Lopez
SoYoung (Sonia) Shin
Isabelle Martel Lafay
Apar Kishor Ganti
Coming IASLC Workshops
December 13-14, 2007
IASLC International Congress on Advances in Pulmonary Neuroendocrine Tumours
Place: London, United Kingdom
Contact: Mr. Eric Lim
For more information: email@example.com
February 21-23, 2008
8th Targeted Therapy Meeting
Place: Santa Monica, CA
For more information: firstname.lastname@example.org
March 19-21, 2008
Perspective in Lung Cancer Treatment
Place: Chaing Mai, Thailand
Contact: Sumitra Thongprasert
For more information: email@example.com
April 24-26, 2008
IASLC/ESMO Lung Cancer Conference
Place: Geneva, Switzerland
Contact: Pia Hirsch
For more information: firstname.lastname@example.org
November 13-15, 2008
Malignancies of the Chest and Head and Neck
Place: Chicago, Illinois
For more information: email@example.com
December 5-7, 2008
3rd Asia Pacific Lung Cancer Congress
For more information: firstname.lastname@example.org
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
WCLC Virtual Library
Multidisciplinary Hands-On Live Learning: Molecular Testing and Personalized Therapy in Lung Cancer - Chicago, ILOctober 14 2016Chicago, IL
Multidisciplinary Hands-On Live Learning: Molecular Testing and Personalized Therapy in Lung Cancer - Philadelphia, PAOctober 21 2016Philadelphia, PA
Multidisciplinary Hands-On Live Learning: Molecular Testing and Personalized Therapy in Lung Cancer - San FranciscoNovember 4 2016San Francisco, CA